TABLE 1

Plasma pharmacokinetic parameters for anti-diabetic drugs in SD and ZDF rats

Rats were given drugs at 1 mg/kg i.v. via femoral vein. Values were derived from plots shown in Fig. 2. Results shown represent mean ± standard deviation from four animals.

ParametersCanagliflozinGlibenclamideRosiglitazoneMetforminTroglitazone
SDZDFSDZDFSDZDFSDZDFSDZDF
AUC (μM*h)5.4 ± 0.68.6 ± 1.6a5.1 ± 1.510 ± 1.5b 40 ± 1232 ± 71.9 ± 0.41.5 ± 0.20.6 ± 0.11.1 ± 0.4a
AUCinf (μM*h)5.8 ± 0.79.7 ± 1.8a5.3 ± 1.624 ± 6.3b40 ± 1232 ± 71.9 ± 0.41.5 ± 0.20.6 ± 0.11.3 ± 0.6a
CL (ml/min per kg)6.5 ± 0.84.0 ± 0.8b 6.8 ± 1.61.5 ± 0.5b1.2 ± 0.31.5 ± 0.371 ± 1690 ± 1463 ± 1035 ± 15a
Vdss (l/kg)3.4 ± 0.32.4 ± 0.3b2.4 ± 0.23.6 ± 0.5b0.3 ± 0.00.2 ± 0.03.4 ± 2.33.7 ± 0.71.6 ± 0.64.7 ± 3.2
t1/2 (h)6.2 ± 0.67.6 ± 0.5b4.8 ± 0.831 ± 9b2.9 ± 0.22.7 ± 0.12.6 ± 3.61.1 ± 0.42.0 ± 1.25.6 ± 4.2
  • AUC, area under the concentration-time curve; AUCinf, AUC extrapolated from time zero extrapolated to infinity; Vdss, volume of distribution at steady state.

  • a P < 0.05 with Student’s t test.

  • b P < 0.01 with Student’s t test.